An antimalarial neem leaf extract has both schizonticidal and gametocytocidal activities

Area of Science:

• Pharmacology
• Parasitology
• Natural Product Chemistry

Background:

• Malaria remains a significant global health challenge, necessitating novel therapeutic strategies.
• Plasmodium falciparum is the deadliest malaria parasite species, responsible for the majority of malaria-related deaths.
• Existing antimalarial drugs face challenges due to parasite resistance and transmission dynamics.

Purpose of the Study:

• To evaluate the in vitro antimalarial activity of a neem leaf extract (IRAB) against Plasmodium falciparum.
• To assess the efficacy of IRAB against both asexual and sexual stages of the parasite.
• To explore the potential of neem extract as a source for new antimalarial drug development.

Main Methods:

• A crude acetone/water (50/50) extract of neem leaves (IRAB) was prepared.
• In vitro cultures of asexual (trophozoites/schizonts) and sexual (gametocytes) Plasmodium falciparum stages were treated with varying concentrations of IRAB (0.5, 2.5, and 5.0 microg/mL).
• Parasitemia levels were quantified after 72-hour incubation periods and compared to control cultures.

Main Results:

• IRAB significantly reduced parasitemia in a dose-dependent manner.
• At 0.5 microg/mL, IRAB reduced asexual and mature gametocyte numbers by over 50%.
• Concentrations of 2.5 microg/mL and 5.0 microg/mL IRAB resulted in near-complete elimination of asexual parasites and gametocytes (including immature forms).

Conclusions:

• Neem leaf extract (IRAB) exhibits potent in vitro activity against Plasmodium falciparum, targeting both asexual and sexual parasite stages.
• IRAB demonstrates potential for the development of novel antimalarial therapeutics.
• The extract's activity against gametocytes suggests a possible role in controlling malaria transmission.